Peptide COAs

Ss 31

26 public audits matching your filters. Scores are PeptIQ’s legitimacy model; missing panels lower thoroughness but aren’t automatically “bad” — open a report to see pass, fail, reported, and missing panels clearly.

Public certificates

Approved community and directory-linked COAs only.

  • SS-31 + SS-31 50mg

    Brand not listed · Jul 28, 2026 · Core panels 100% · 3/7 panels · 99.63% purity

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns88Doc score
  • SS-31 + SS-31 10mg

    Brand not listed · Jul 28, 2026 · Core panels 100% · 3/7 panels · 99.95% purity

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns88Doc score
  • SS-31 + SS-31 10mg

    American Peptides · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.7% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns80Solid
  • MTS-31 + SS-31

    Crush Research · Sep 5, 2026 · Core panels 100% · 5/7 panels · 99.61% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns79Solid
  • SS-31

    Blank Peptides · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.48% purity · Doc 88

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns76Solid
  • SS-31

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • SS-31

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.83% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • SS-31

    Peptide Partners · Sep 5, 2026 · Core panels 33% · 1/7 panels · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • SS-31

    Peptide Partners · Sep 5, 2026 · Core panels 33% · 1/7 panels · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • SS-31

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 2/7 panels · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • SS-31

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • SS-31

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 88

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • SS-31

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.67% purity · Doc 88

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • SS-31

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 88

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • SS-31

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.7% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • SS-31

    Retalux · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.9% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns71Solid
  • SS-31 + Elamipritide

    Retalux · Sep 5, 2026 · Core panels 100% · 4/7 panels · 99.9% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns71Solid
  • SS-31 + Elamipritide

    Retalux · Sep 5, 2026 · Core panels 100% · 4/7 panels · 99.9% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns71Solid
  • SS-31

    Retalux · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.57% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns71Solid
  • SS-31

    Koi Peptides · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.924% purity · Doc 88

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns65Mixed signals
  • SS-31 + Elamipritide

    Pepturion · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.9% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns63Mixed signals
  • SS-31 + Elamipritide

    Pepturion · Sep 5, 2026 · Core panels 100% · 4/7 panels · 99.9% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns63Mixed signals
  • SS-31

    BioLongevity Labs · Sep 5, 2026 · Core panels 33% · 1/7 panels · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns59Mixed signals
  • SS-31

    BioLongevity Labs · Sep 5, 2026 · Core panels 33% · 1/7 panels · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns59Mixed signals
  • SS31

    BioLongevity Labs · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.79% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns59Mixed signals
  • SS-31

    Lumira · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.8% purity · Doc 88

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns58Mixed signals

Community-sourced

Help build the COA record

PeptIQ’s market snapshot comes from moderator-approved certificates and curated peptide brands and testing laboratories — not invented stats. Contribute a COA or claim your listing.

Community submissions are reviewed before they appear on public market pages. Private COA scans stay private until you share them.

Brand owners: claim or list your peptide brand, upload COAs tied to it in the app, then track trust scores on your public brand page and the COA market.

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.